Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Document Type
- Journal article (10)
Language
- English (10)
Keywords
- Aspergillus (3)
- invasive aspergillosis (2)
- Aspergillus fumigatus (1)
- Aspergillus sp. (1)
- B cells (1)
- CAPA (1)
- COVID-19 (1)
- Candida sp. (1)
- Fusarium (1)
- Invasive Aspergillosis (1)
- MAPKAPK2 (1)
- NFkB-relatedgenes (1)
- Rhizopus arrhizus (1)
- T cells (1)
- TNFSF14 (1)
- TNFSF4 (1)
- TSLP (1)
- allogeneic stem cell transplantation (1)
- alveolar epithelium (1)
- beta-D-glucan (1)
- bronchoalveolar lavage fluid (1)
- cytokines (1)
- dendritic cells (1)
- diagnostics (1)
- fluorescence in situ hybridization (FISH) (1)
- fungal aerosolization (1)
- fungal infection (1)
- fungal infections (1)
- fungal molecular diagnostics (1)
- fungal sinusitis (1)
- galactomannan (1)
- gene expression data (1)
- genetic polymorphisms (1)
- genetic susceptibility (1)
- human biomarker (1)
- in vitro model (1)
- interaction (1)
- invasive fungal infection (1)
- mixed infection (1)
- molecular diagnosis (1)
- monocytes (1)
- mucormycosis (1)
- multiplex PCR (1)
- pediatric (1)
- porcine large animal model (1)
- probe-based real-time PCR (1)
- pulmonary immune response (1)
- real-time PCR (1)
- serum biomarkers (1)
- susceptibility (1)
Institute
EU-Project number / Contract (GA) number
- 847507 (1)
The COVID-19 pandemic has resulted in large numbers of patients requiring critical care management. With the established association between severe respiratory virus infection and invasive pulmonary aspergillosis (7.6% for COVID-19-associated pulmonary aspergillosis (CAPA)), the pandemic places a significant number of patients at potential risk from secondary invasive fungal disease. We described a case of CAPA with substantial supporting mycological evidence, highlighting the need to employ strategic diagnostic algorithms and weighted definitions to improve the accuracy in diagnosing CAPA.